Fleg Jerome L, Keteyian Steven J, Peterson Pamela N, Benzo Roberto, Finkelstein Joseph, Forman Daniel E, Gaalema Diann E, Cooper Lawton S, Punturieri Antonello, Joseph Lyndon, Shero Susan, Zieman Susan
National Heart Lung and Blood Institute, Bethesda, Maryland (Drs Fleg, Cooper, and Punturieri and Ms Shero); Henry Ford Hospital, Detroit, Michigan (Dr Keteyian); Denver Health Medical Center, Denver, and University of Colorado Anschutz Medical Center, Aurora, Colorado (Dr Peterson); Mayo Clinic, Rochester, Minnesota (Dr Benzo); Icahn School of Medicine at Mount Sinai, New York (Dr Finkelstein); University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Forman); University of Vermont, Burlington (Dr Gaalema); and National Institute on Aging, Bethesda, Maryland (Drs Joseph and Zieman).
J Cardiopulm Rehabil Prev. 2020 Nov;40(6):350-355. doi: 10.1097/HCR.0000000000000527.
Although both cardiac rehabilitation (CR) and pulmonary rehabilitation (PR) are recommended by clinical practice guidelines and covered by most insurers, they remain severely underutilized. To address this problem, the National Heart, Lung, and Blood Institute (NHLBI), in collaboration with the National Institute on Aging (NIA), developed Funding Opportunity Announcements (FOAs) in late 2017 to support phase II clinical trials to increase the uptake of CR and PR in traditional and community settings. The objectives of these FOAs were to (1) test strategies that will lead to increased use of CR and PR in the US population who are eligible based on clinical guidelines; (2) test strategies to reduce disparities in the use of CR and PR based on age, gender, race/ethnicity, and socioeconomic status; and (3) test whether increased use of CR and PR, whether by traditional center-based or new models, is accompanied by improvements in relevant clinical and patient-centered outcomes, including exercise capacity, cardiovascular and pulmonary risk factors, and quality of life. Five NHLBI grants and a single NIA grant were funded in the summer of 2018 for this CR/PR collaborative initiative. A brief description of the research to be developed in each grant is provided.
尽管心脏康复（CR）和肺康复（PR）均得到临床实践指南的推荐，且大多数保险公司都予以承保，但它们的利用率仍然极低。为解决这一问题，美国国立心肺血液研究所（NHLBI）与国立衰老研究所（NIA）合作，于2017年末发布了资助机会公告（FOA），以支持二期临床试验，从而提高CR和PR在传统及社区环境中的接受程度。这些FOA的目标包括：（1）测试能促使符合临床指南的美国人群更多使用CR和PR的策略；（2）测试减少基于年龄、性别、种族/族裔及社会经济地位的CR和PR使用差异的策略；（3）测试增加CR和PR的使用（无论是通过传统的基于中心的模式还是新模式）是否会伴随相关临床及以患者为中心的结局的改善，包括运动能力、心血管和肺部危险因素以及生活质量。2018年夏季，有五项NHLBI资助和一项NIA资助获批用于此项CR/PR合作项目。以下简要介绍每项资助所开展的研究。
